Patents Assigned to EmboMedics, Inc.
  • Patent number: 10182979
    Abstract: The present disclosure describes a plurality of microspheres that include carboxymethyl chitosan (CCN) crosslinked with carboxymethyl cellulose (CMC). The microspheres are biocompatible, bioresorbable, and biodegradable. The microspheres may be used in personal care products, such as, for example, toothpaste, topical pain relief products, topical antibiotic products, skincare products such as anti-wrinkle products, eczema products, skin scrubs, acne cleansers, exfoliators, body washes, soaps, pre-shave creams, or the like.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: January 22, 2019
    Assignees: Regents of the University of Minnesota, EmboMedics, Inc.
    Inventors: Lihui Weng, Jafar Golzarian, Omid Souresrafil